The estimated Net Worth of Lawrence P. Wennogle is at least $10.8 Milion dollars as of 8 June 2015. Lawrence Wennogle owns over 25,000 units of Intra-Cellular Therapies Inc stock worth over $9,452,080 and over the last 10 years Lawrence sold ITCI stock worth over $1,361,000.
Lawrence has made over 10 trades of the Intra-Cellular Therapies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Lawrence sold 25,000 units of ITCI stock worth $671,000 on 8 June 2015.
The largest trade Lawrence's ever made was exercising 47,500 units of Intra-Cellular Therapies Inc stock on 19 May 2015 worth over $58,425. On average, Lawrence trades about 13,000 units every 32 days since 2014. As of 8 June 2015 Lawrence still owns at least 126,500 units of Intra-Cellular Therapies Inc stock.
You can see the complete history of Lawrence Wennogle stock trades at the bottom of the page.
Lawrence's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 3960 BROADWAY, NEW YORK, NY, 10032.
Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus oraz Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: